Project

Anti-PD-L1 antibody MEDI4736 in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC). A multicenter single-arm phase II trial.

Completed - recruitment closed · 2016 until 2024

Frueh Martin, Breuss Kim, Quinter Janine